Adamis Pharmaceuticals Corp (ADMP)

[H2R]

One Day Left Before PDUFA 9/27 :)

Symjepi Jr., the low-dose version of Adamis’ Symjepi epinephrine prefilled syringe, faces a PDUFA decision expected Thursday, Sep. 27

Not too long to wait for the decision on Jr!

What I hope is that the commercial plans will be made public and the stock can take off!

The PDUFA date for Symjepi jr. (0.15mg) is approaching on 9/27/18, we expect a positive response from the FDA. Symjepi (0.3mg & 0.15mg) is partnered to Sandoz-Novartis. Our expectation is that Sandoz will launch both Symjepi products sometime in the second half following low-dose approval (though precise timing has not been announced)